Corbus Pharma (CRBP) Misses Q2 EPS by 55c
Tweet
Share
E-mailGet Alerts CRBP Hot Sheet
Join SI Premium – FREE
Corbus Pharma (NASDAQ: CRBP) reported Q2 EPS of ($1.81), $0.55 worse than the analyst estimate of ($1.26).
For earnings history and earnings-related data on Corbus Pharma (CRBP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- loanDepot receives NYSE non-compliance notice over stock price
- Hinge Health signs $86M office lease in San Francisco
- QSE closes $6M private placement with final tranche of $674K
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
